Live streaming starts at 8:30am PT (11:30am ET)
Live streaming starts at 8:30am PT (11:30am ET)
In the post-epidemic era, the healthcare field is in a stage of recovery and transformation. In North America, the addition of artificial intelligence has brought about earth-shaking changes in drug research and development and medical methods, with biotechnology companies benefiting the most. The North American drug market reaches US$480 billion, accounting for approximately 43% of the global total. A large number of emerging technologies and drugs are in the experimental stage and may be approved for marketing at any time.
Investing in biotech and life science offers the potential for high returns due to groundbreaking medical discoveries, innovative therapies, and a growing demand for healthcare solutions. Investors need to remain updated and adaptable to capitalize on the emerging investment opportunities in these innovative sectors.
GCFF Bio Investing Conference 2024(Virtual) will be held on June 20, 2024, and will provide investors with an analysis of the latest trends in biotech, life-science and healthcare market.
This event is suitable for the following:
Individual investors, private client brokers, financial institutions, buy & sell side analysts and journalists, Business and Economics major students.
